Protein kinase C co-expression and the effects of halothane on rat skeletal muscle sodium channels

J P Mounsey1, M K Patel, D Mistry

  • 1Department of Internal Medicine (Cardiovascular Division), Box 6012, MR4 Building, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA. pmounsey@virginia.edu

Insights

Protein kinase C (PKC) activity modulates how volatile anesthetics affect voltage-gated sodium channels. Halothane

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Voltage-gated sodium channels are targets for general anesthetics.
  • Protein kinase C (PKC) phosphorylates a key site on sodium channels.

Purpose of the Study:

  • To investigate if PKC modulates volatile anesthetic effects on sodium channels via phosphorylation.
  • To explore the interaction between halothane, PKC, and sodium channel inactivation.

Main Methods:

  • Expressed rat skeletal muscle sodium channel alpha-subunits in Xenopus oocytes.
  • Measured sodium currents using two-microelectrode voltage clamp.
  • Modulated PKC activity by co-expressing a constitutively active PKC alpha-isozyme.

Main Results:

  • Halothane alone had no effect on sodium currents.
  • Co-expression of PKC with halothane enhanced sodium current decay rate and reduced amplitude.
  • This enhancement of decay was abolished in a mutant lacking the inactivation gate phosphorylation site.

Conclusions:

  • PKC activity enables halothane to hasten sodium current decay and reduce amplitude, partly via the inactivation gate phosphorylation site.
  • The interaction between halothane and sodium channels may be direct, facilitated by PKC and phosphorylation.

Related Concept Videos

Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...